Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Secondary brain tumors (metastases) arise from
Tumors outside CNS spreading to CNS (usually via hematogenous dissemination)
Primary CNS neoplasms spreading from 1 site to another (usually geographic extension, e.g., along WM tracts)
General features
Round enhancing lesion(s) at gray-white interface (arterial border zones)
Most metastases are circumscribed/discrete > > infiltrating, spherical > > linear
50% are solitary; 20% have 2 metastases
30% of patients have 3 or more
MR signal intensity varies with
Cellularity, nuclear:cytoplasmic ratio
Presence/absence of hemorrhage
Usually no restriction on DWI
Exception: Densely cellular metastases may restrict
Abscess (solitary or multiple)
Glioblastoma multiforme
Cerebral infarction (multiple embolic)
Demyelinating disease (e.g., tumefactive MS)
Metastases represent at least 50% of all brain tumors
In 10% of cases, brain is only site
Progressive increase in size and numbers is typical
Median survival with whole-brain XRT = 3-6 months
Stereotactic radiosurgery alone > whole-brain XRT
Survival advantage, if 1-4 metastases, avoids deleterious effects of whole-brain XRT on quality of life, cognition
Resection of solitary metastasis may improve survival
Parenchymal metastases (mets)
Secondary brain tumors
Body-to-brain metastases
Brain-to-brain metastases
Secondary brain tumors (metastases) arise from
Tumors outside CNS that spread to CNS (usually via hematogenous dissemination)
Primary CNS neoplasms that spread from one site to another (usually geographic spread, e.g., along white matter [WM] tracts)
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here